pharma news today glp-1 obesity drugs today drug supply Giants Bet on Next-Generation GLP-1 Treatments The GLP-1 Access Gap: Mapping
Description
Outcomes depend on your medical indication, nutrition, physical activity, and biological response
#pharma #biotech #medtech #clinicaltrials #innovation #cholesterol #lipids #cardiachealth To view or add a comment, sign in Eli Lillys obesity and diabetes drug Mounjaro has quickly become a major player in Indias pharmaceutical market, achieving impressive sales milestones within just six months of its launch
That model is now being disrupted
Cell Metabolism 27740756
Kelly AS, Metzig AM, Rudser KD, Fitch AK, Fox CK, Nathan BM, et al
The truth is simple but inconvenient: GLP-1 medications are a powerful tool not a complete solution
